Jci_page_head_homepage_01 Jci_page_head_homepage_02
Alexandra Zanin-Zhorov, Liora Cahalon, Guy Tal, Raanan Margalit, Ofer Lider, Irun R. Cohen
Published in Volume 116, Issue 7
J Clin Invest. 2006; 116(7):2022–2032 doi:10.1172/JCI28423
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1
HSP60 pretreatment inhibits anti-CD3–induced IFN-γ and TNF-α secretion and upregulates IL-10 secretion by activated CD3+ and CD4+ T cells, but not by CD8+ T cells.

Purified CD3+, CD4+, or CD8+ T cells were preincubated with the indicated concentrations of HSP60 for 2 hours, washed, and transferred to 24-well plates coated with anti-CD3 mAb (OKT; 0.5 μg/ml) in serum-free medium. The supernatants were collected after 24 hours and analyzed for IFN-γ (A), TNF-α (B), and IL-10 (C). The means ± SD of 5 different donors are shown. *P < 0.05.